BillionToOne, Inc.
Company Information
Industry
Services-Medical Laboratories
SIC Code
8071
Entity Type
operating
SEC Category
Non-accelerated filerEmerging growth company
State of Incorporation
DE
Business Address
1035 O'BRIEN DRIVE, MENLO PARK, CA,
Mailing Address
1035 O'BRIEN DRIVE, MENLO PARK, CA, 94025
Phone
650-460-2551
Fiscal Year End
1231
EIN
811082020
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 11, 2026 | View on SEC |
| 8-K Current report of material events | March 4, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 17, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 17, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 13, 2026 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | January 20, 2026 | View on SEC |
| 4 Insider stock transaction report | January 20, 2026 | View on SEC |
| 3 Initial insider ownership report | January 20, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
IPO Filings
S-1
October 7, 2025
- Advanced medical testing technology with 10x higher precision than competitors, focusing on prenatal and cancer diagnostics.
- Rapid revenue growth: 113% increase in 2024 ($152.6M) and 82% growth in first half of 2025 ($125.5M).
Annual Reports
10-K
March 11, 2026
- Successfully completed its Initial Public Offering (IPO) on November 7, 2025, transitioning to public ownership.
- Operates in three primary advanced diagnostics areas: prenatal, oncology, and clinical trial support.
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.